AffiliationCR-UK Department of Medical Oncology, Christie Hospital NHS Trust, University of Manchester, Wilmslow Road, Manchester, M20 4BX, UK. firstname.lastname@example.org
MetadataShow full item record
CitationCommentary on ZD1839 (Iressa) in non small cell lung cancer. 2003, 40 (1):77-8 Lung Cancer
- ZD1839 (Iressa) in non-small cell lung cancer.
- Authors: Herbst RS, Kies MS
- Issue date: 2002
- Clinical development of gefitinib in non-small-cell lung cancer and the Iressa Survival Evaluation in Lung Cancer trial.
- Authors: Price N, Belani C
- Issue date: 2005 Jan
- Gefitinib ('Iressa', ZD1839) may restore chemosensitivity in NSCLC patients?
- Authors: Fujiwara K, Kiura K, Gemba K, Ogata Y, Hotta K, Kishino D, Tabata M, Ueoka H, Tanimoto M
- Issue date: 2005 Jan-Feb
- Gefitinib (Iressa): a novel treatment for non-small cell lung cancer.
- Authors: Vansteenkiste J
- Issue date: 2004 Feb
- Effects of ZD1839 (Iressa, gefitinib) treatment on symptoms and quality of life in patients with advanced non-small cell lung cancer.
- Authors: Natale RB
- Issue date: 2004 Jun